R1 RCM Inc. (OTCMKTS:ACHI) Files An 8-K Regulation FD DisclosureItem 7.01 Regulation FD Disclosure.
On April 17, 2018, R1 RCM Inc. (the “Company”) will make a presentation to potential lenders in connection with the Company’s previously announced first lien senior secured credit facility relating to the financing of the Company’s pending merger with Intermedix Holdings, Inc. A copy of the lender presentation is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated by reference herein.
The information contained in Item 7.01 of this Current Report on Form 8-K, including Exhibit 99.1, is being furnished and shall not be deemed “filed” for purposes of Section18 of the Securities Exchange Act of 1934, as amended nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing.
Item 9.01 Financial Statements and Exhibits.
Lender Presentation dated April 17, 2018
R1 RCM INC. ExhibitEX-99.1 2 projectlinkslppublicvf.htm EXHIBIT 99.1 projectlinkslppublicvf Lender Presentation
April 17,…To view the full exhibit click
About R1 RCM Inc. (OTCMKTS:ACHI)
R1 RCM Inc., formerly Accretive Health, Inc., is a provider of revenue cycle services to healthcare providers. The Company offers revenue cycle management (RCM) service and physician advisory services (PAS). The Company operates through the business of providing end-to-end management services of revenue cycle operations for the United States-based hospitals and other medical providers segment. It also offers modular services, allowing clients to engage in specific components of its RCM service offering. Its customers are single or multi-hospital healthcare systems, including faith-based healthcare systems, community healthcare systems, academic medical centers and their affiliated ambulatory clinics, and physician practice groups. The Company’s population health solutions (PHS) services are designed to enable healthcare providers to manage the health of a defined patient population by identifying various individuals. The Company utilizes the R1 Performance Stack.